Manh-Cuong Vo - Concepedia

Author

Manh-Cuong Vo

Chonnam National University Hwasun Hospital ORCID

Also Known As

M Vo, M. Vo, Manh-Cuong Vo, Manh-cuong Vo, Mộng Thường Võ

Publications

583

Citations

H-Index

Concepts

All Affiliations

Chonnam National University Hwasun Hospital Chonnam National University Samsung Medical Center Sungkyunkwan University Chonnam National University Hospital

About

Manh-Cuong Vo is an author at Chonnam National University Hwasun Hospital specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	273
2	Cell Biology	8	8	205
3	Engineering	1	1	32
4	Natural Sciences	1	1	15
5	Cellular Physiology	1	1	12

Manh-Cuong Vo

Publications

483

Citations

H-Index

Page 1

	Year	Citations
A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine Hyun Jin Park, Gun-Young Jang, Young Seob Kim, Journal for ImmunoTherapy of Cancer	2019	46
Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma Thanh-Nhan Nguyen-Pham, Sung‐Hoon Jung, Manh-Cuong Vo, Journal of Immunotherapy Dendritic CellImmunologyImmune RegulationImmunoeditingImmunologic Mechanism	2015	42
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung‐Hoon Jung, Cellular and Molecular Immunology Cancer ImmunosurveillanceAntimyeloma EffectImmunologyMouse ModelImmune Checkpoint Inhibitor	2021	42
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model Manh-Cuong Vo, Thanh-Nhan Nguyen-Pham, Hyunju Lee, Oncotarget	2017	39
Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma Manh-Cuong Vo, Sung‐Hoon Jung, Tan-Huy Chu, Frontiers in Immunology	2018	38
Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma Manh-Cuong Vo, Truc Anh-NguyenThi, Hyunju Lee, Experimental Hematology Hematological MalignancyMalignant Blood DisorderImmunologyAutoimmunityMultiple Myeloma	2016	35
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21 Jaya Lakshmi Thangaraj, Minh‐Trang Thi Phan, SoonHo Kweon, Cancer Immunology Immunotherapy Hematological MalignancyImmunologyK562 CellsAutoimmunityMultiple Myeloma Patients	2021	33
Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells My-Dung Hoang, Hwa‐Jeong Lee, Hyunju Lee, Journal of Immunology Research NanoparticlesEngineeringDendritic CellImmunologyImmunotherapy	2015	32
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma Tan-Huy Chu, Manh-Cuong Vo, Hye-Seong Park, Cancer Immunology Immunotherapy Hematological MalignancyOncologyMedicineImmunologyDendritic Cell Therapy	2020	26
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model Jaya Lakshmi Thangaraj, Sung‐Hoon Jung, Manh-Cuong Vo, Cancer Immunology Immunotherapy	2022	21

Page 1